Validation of the Andon KD-5917 automatic upper arm blood pressure monitor, for clinic use and self-measurement, according to the European Society of Hypertension International Protocol revision 2010

  • Wan Gang Guo
  • , Bing Ling Li
  • , Yong He
  • , Yu Sheng Xue
  • , Hai Yan Wang
  • , Qiang Sun Zheng
  • , Ding Cheng Xiang

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

OBJECTIVE: To validate the Andon KD-5917 automatic upper arm blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. MATERIALS AND METHODS: Sequential same-left-arm measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP) were obtained in 33 participants using the mercury sphygmomanometer and the test device. According to the validation protocol, 99 pairs of test device and reference blood pressure measurements (three pairs for each of the 33 participants) were obtained in the study. RESULTS: The device produced 73, 98, and 99 measurements within 5, 10, and 15 mmHg for SBP and 86, 98, and 99 for DBP, respectively. The mean±SD device-observer difference was 3.07±3.68 mmHg for SBP and -0.89±3.72 mmHg for DBP. The number of patients with two or three of the device-observer difference within 5 mmHg was 26 for SBP and 29 for DBP, and no patient had a device-observer difference within 5 mmHg. CONCLUSION: The Andon KD-5917 automatic upper arm blood pressure monitor can be recommended for clinical use and self-measurement in an adult population on the basis of the European Society of Hypertension International Protocol revision 2010.

Original languageEnglish
Pages (from-to)242-245
Number of pages4
JournalBlood Pressure Monitoring
Volume19
Issue number4
DOIs
StatePublished - Aug 2014
Externally publishedYes

Keywords

  • European Society of Hypertension
  • blood pressure
  • international protocol
  • validation

Fingerprint

Dive into the research topics of 'Validation of the Andon KD-5917 automatic upper arm blood pressure monitor, for clinic use and self-measurement, according to the European Society of Hypertension International Protocol revision 2010'. Together they form a unique fingerprint.

Cite this